Case report: Cytopenias in VEXAS syndrome - a WHO 2022 based approach in a single-center cohort

Case report: Cytopenias in VEXAS syndrome - a WHO 2022 based approach in a single-center cohort

VEXAS syndrome is an acquired autoinflammatory disease characterized in most cases by cytopenias and macrocytic anemia. Dyshematopoiesis is a frequent finding in chronic inflammatory conditions and therefore, cytopenias are not easily classified in VEXAS patients. Here we report a series of 7 patien...

Full description

Bibliographic Details
Main Authors: Elisa Diral, Corrado Campochiaro, Alessandro Tomelleri, Gregorio M. Bergonzi, Umberto Pizzano, Maurilio Ponzoni, Lucia Bongiovanni, Paola Ronchi, Cristina Tresoldi, Silvia Rigamonti, Federico Scarfò, Gloria M. Latino, Emma Rinaldi, Massimo Bernardi, Lorenzo Dagna, Fabio Ciceri
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-01-01
Series:Frontiers in Immunology
Subjects:
myelodysplastic neoplasms (MDS)
VEXAS syndrome
next generating sequencing
azacytidine
ruxolitinib
vacuoles
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2024.1354130/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2024.1354130/full

Similar Items